Newly disclosed contracts show Pfizer and Eli Lilly's drug-pricing agreements with President Donald Trump included undisclosed tariff protections and incentives to raise prices overseas, according to records obtained through a watchdog group's lawsuit.
Continue reading...
[ H/T Newsmax ]
